(Total Views: 687)
Posted On: 08/12/2020 7:23:05 AM
Post# of 154056
Quote:
THEY EITHER NEED TO UPLIST OR MAKE A DEAL.
So what do you think would be an appropriate offer that NP and the Board should put up for a vote? Now stop and think about it again. How much is a company worth that has a drug that has shown the best results for m/m in a proper trial. Now add blowing the doors off remdesivir in severe/critical. Now add 60+ potential indications. Now weren't you thinking to low?
Quote:
they will have to prove severe beyond a shadow of a doubt p=.0003 at this point.
Since remdesivir has no statistical significance for mortality the FDA would be chastised for denying EUA to any drug that does taking the confidence interval into account.
(5)
(0)
